Spirometer Market Outlook: Rising Prevalence of Respiratory Diseases and Increasing Focus on Pulmonary Health Driving Market Growth

According to IMARC Group's latest research publication, The global spirometer market size reached USD 1,227.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,468.2 Million by 2033, exhibiting a growth rate (CAGR) of 7.67% during 2025-2033.

How AI is Reshaping the Future of Spirometer Market

• Automated Quality Control and Test Interpretation: AI software analyzes spirometry curves with 91% agreement rates compared to expert over-readers, achieving 97% sensitivity and 93% positive predictive value. These systems eliminate subjective interpretation variability, reduce average interpretation time from 10.6 minutes to 5.6 minutes, and ensure consistent quality assessment across clinical trials and primary care settings.
• Enhanced Diagnostic Accuracy Through Machine Learning: Decision tree algorithms incorporating lung function and clinical variables double overall diagnostic accuracy to 68%, improving positive predictive values for COPD to 83%, asthma to 66%, and interstitial lung disease to 52%. Neuro-fuzzy systems achieve over 99% accuracy in classifying asthma and COPD by integrating spirometric parameters with clinical symptoms.
• Remote Patient Monitoring and Telemedicine Integration: Portable smart spirometers equipped with AI-powered sensors wirelessly transmit real-time respiratory data—including rate, oxygen saturation, and cough frequency—to clinicians. These devices enable continuous tracking for over 50 million patients worldwide, facilitating early exacerbation detection and personalized treatment adjustments outside traditional hospital settings.

Explore Updated 2026 Market Trends & Analysis

Spirometer Industry Overview:

Rising respiratory disease prevalence and air quality deterioration are fundamentally driving spirometer demand worldwide. Over 334 million people suffer from asthma while more than 65 million experience COPD globally, with chronic respiratory diseases ranking as the third leading cause of death, claiming 3.23 million lives annually. Tobacco consumption among working professionals, escalating urbanization, and deteriorating air quality in emerging economies have intensified lung disorder incidence. The aging population, particularly susceptible to chronic respiratory conditions, further amplifies testing requirements as portable and connected diagnostic solutions become essential for early detection and continuous disease management across clinical and home care environments.

Spirometer Market Trends & Drivers

Technological innovation in portable and connected devices is transforming respiratory diagnostics beyond traditional clinical settings. In January 2024, NuvoAir Medical received FDA 510(k) clearance for Air Next Spirometer, enabling home-based testing for patients with COPD, asthma, and ALS. In September 2023, Alveofit secured FDA approval for alveoair, India's first US FDA-cleared portable digital spirometer adopted by over 400 healthcare facilities across India and supported by an AstraZeneca partnership for international expansion. These wireless, Bluetooth-enabled devices connect seamlessly to smartphones and tablets, transmitting comprehensive lung function data including FEV1, FVC, and flow-volume curves directly to healthcare providers.

Telemedicine proliferation and remote patient monitoring programs are democratizing access to pulmonary function testing, particularly in underserved populations. In March 2024, Vitalograph launched its next-generation spirometry platform featuring AI-powered diagnostics and cloud-based data management, enabling real-time patient monitoring capabilities across multiple clinical settings. In October 2023, Med Company partnered with Sananet to integrate the Spirobank Smart Spirometer into the MedCor4U App, allowing OLVG and HagaZiekenhuis patients to perform lung function tests from home with results instantly accessible to providers through SananetOnline and SanaCoach Asthma platforms. Primary care physicians historically avoided spirometry due to insufficient training, lack of experience, and logistic concerns.

Government initiatives and regulatory support are accelerating market penetration through strategic healthcare infrastructure investments. Japan's rapidly aging population has prompted government-led initiatives reducing respiratory disease burden, focusing on smart, compact remote spirometry solutions for chronic disease management in clinical and homecare settings. The United States, with over 16 million COPD cases, implements policies supporting remote monitoring and spirometry inclusion in primary care, backed by increased healthcare spending and public-private investments in diagnostic technologies. In February 2024, Aptar Pharma launched HeroTracker Sense, converting traditional pressurized metered dose inhalers into smart devices, demonstrating industry shifts toward integrated digital health ecosystems.

Leading Companies Operating in the Global Spirometer Industry:

• Benson Medical Instruments
• Chest M.I.
• Fukuda Sangyo
• Hill-Rom Inc.
• Jones Medical Instrument Company
• Medical International Research
• Midmark Corporation
• NDD Medizintechnik AG
• Schiller AG
• Vitalograph
• Vyaire Medical
• Welch Allyn Inc.

Spirometer Market Report Segmentation:

By Product:

• Consumables & Accessories
• Devices
• Software

The report has provided a detailed breakup and analysis of the spirometer market based on the product.

By Mechanism:

• Flow-Sensing Spirometers
• Peak Flow Meters
• Others

A detailed breakup and analysis of the spirometer market based on the mechanism has also been provided in the report.

By Application:

• COPD
• Asthma
• Others

A detailed breakup and analysis of the spirometer market based on the application has also been provided in the report.

By Disposable Components:

• Filters
• Tubes
• Sensors

The report has provided a detailed breakup and analysis based on the disposable components.

By End-User:

• Hospitals
• Clinical Laboratories
• Home Care Settings
• Others

A detailed breakup and analysis of the spirometer market based on the end-user has also been provided in the report.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

The report has provided a comprehensive analysis of all the major regional markets.

Recent News and Developments in Spirometer Market

• December 2024: Vyaire Medical expanded its spirometry product portfolio with the introduction of advanced portable devices specifically designed for home healthcare applications. The new devices address growing demand for remote patient monitoring solutions while maintaining clinical-grade accuracy standards, enabling patients with chronic respiratory conditions to track lung function from home with professional-level precision.
• March 2024: Vitalograph announced the launch of its next-generation spirometry platform featuring AI-powered diagnostics and cloud-based data management. The innovative system enables healthcare providers to offer enhanced respiratory care services with real-time patient monitoring capabilities across multiple clinical settings, streamlining workflow and improving diagnostic consistency.
• February 2024: Aptar Pharma launched HeroTracker Sense, an innovative digital respiratory health solution designed to convert traditional pressurized metered dose inhalers into smart devices. This development demonstrates the industry's strategic shift toward integrated digital health ecosystems and connected medical devices that enhance medication adherence tracking and patient engagement.
• January 2024: NuvoAir Medical received FDA 510(k) clearance for Air Next Spirometer, a home-use device for patients with conditions including COPD, asthma, and ALS. The clearance enables widespread home-based pulmonary function testing, empowering patients to monitor respiratory health independently while providing clinicians with reliable data for treatment optimization.
• April 2024: Clario completed the acquisition of ArtiQ, a technology company specializing in artificial intelligence applications for respiratory diagnostics. This strategic acquisition enhances Clario's Respiratory Solutions portfolio by incorporating advanced AI capabilities, improving clinical trial efficiency and effectiveness through automated spirometry quality assessment and interpretation support.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.